VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
KYMR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
KYMRKymera Therapeutics, Inc.
$109.32$8.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksKYMRQuarterly Financials

Kymera Therapeutics, Inc. (KYMR) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Kymera Therapeutics, Inc. (KYMR) quarterly income statement — complete revenue, gross profit & net income history

KYMR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue34.37M2.86M2.76M11.48M22.1M7.39M3.74M25.65M10.29M47.88M4.73M16.51M9.47M16.14M9.55M11.51M9.62M15.28M20.34M18.52M
Revenue Growth %55.5%-61.32%-26.12%-55.26%114.83%-84.56%-20.88%55.33%8.67%196.7%-50.5%43.42%-1.62%5.66%-53.03%-37.83%-48.55%19.48%39.93%463.23%
Cost of Goods Sold0-76.18M74.09M2.08M0000000000000000
COGS % of Revenue--2663.57%2680.68%18.16%----------------
Gross Profit079.04M-71.33M9.39M22.1M7.39M3.74M25.65M10.29M47.88M4.73M16.51M9.47M16.14M9.55M11.51M9.62M15.28M20.34M18.52M
Gross Margin %-2763.57%-2580.68%81.84%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%
Gross Profit Growth %-100%968.95%-2006.71%-63.38%114.83%-84.56%-20.88%55.33%8.67%196.7%-50.5%43.42%-1.62%5.66%-53.03%-37.83%-48.55%19.48%39.93%463.23%
Operating Expenses118.52M176.93M21.19M93.95M96.53M88.15M75.86M76.58M68.12M67.2M62.24M59.9M54.79M54.77M54.43M52.32M46.55M49.27M48.97M43.25M
OpEx % of Revenue344.88%6186.5%766.68%818.66%436.77%1192.17%2027.93%298.54%662.18%140.33%1316.35%362.72%578.83%339.36%569.92%454.44%483.84%322.55%240.82%233.54%
Selling, General & Admin20.36M16.95M17.34M17.64M16.27M16.33M15.46M17.37M14.37M14.23M14.12M14.13M12.56M11.64M10.56M11.03M10.61M11.74M10.67M8.03M
SG&A % of Revenue59.24%592.59%627.21%153.76%73.62%220.88%413.12%67.73%139.73%29.71%298.65%85.56%132.74%72.1%110.52%95.81%110.28%76.86%52.45%43.36%
Research & Development98.16M83.86M74.09M78.39M80.25M71.82M60.41M59.2M48.82M52.97M48.12M45.77M42.23M43.13M43.88M41.29M35.94M37.53M38.31M35.22M
R&D % of Revenue285.65%2932.27%2680.68%683.06%363.14%971.29%1614.81%230.81%474.57%110.62%1017.7%277.16%446.09%267.26%459.4%358.63%373.56%245.7%188.37%190.18%
Other Operating Expenses01000K-1000K-1000K00001000K00000000000
Operating Income-84.15M-97.9M-92.52M-84.56M-74.43M-80.75M-72.12M-50.92M-57.83M-19.31M-57.51M-43.38M-45.33M-38.63M-44.88M-40.81M-36.93M-33.99M-28.64M-24.73M
Operating Margin %-244.88%-3422.94%-3347.36%-736.82%-336.77%-1092.17%-1927.93%-198.54%-562.18%-40.33%-1216.35%-262.72%-478.83%-239.36%-469.92%-354.44%-383.84%-222.55%-140.82%-133.54%
Operating Income Growth %-13.07%-21.23%-28.28%-66.04%-28.7%-318.16%-25.41%-17.38%-27.59%50.01%-28.13%-6.3%-22.72%-13.64%-56.73%-65.02%-180.45%-165.95%-254.29%-74.25%
EBITDA-84.15M-95.86M-89.67M-82.47M-72.38M-78.77M-70.14M-48.99M-56.37M-18.45M-56.61M-42.48M-44.43M-37.81M-44.12M-40.1M-36.25M-33.3M-27.97M-24.18M
EBITDA Margin %-244.88%-3351.89%-3244.28%-718.66%-327.5%-1065.3%-1874.82%-190.98%-547.97%-38.52%-1197.31%-257.27%-469.32%-234.29%-461.89%-348.32%-376.7%-218.04%-137.52%-130.56%
EBITDA Growth %-16.27%-21.7%-27.85%-68.36%-28.4%-327%-23.9%-15.31%-26.89%51.21%-28.32%-5.93%-22.57%-13.53%-57.75%-65.87%-185.76%-171.1%-268.31%-75.16%
D&A (Non-Cash Add-back)02.03M2.85M2.08M2.05M1.99M1.99M1.94M1.46M865K900K900K900K818K767K705K687K689K671K552K
EBIT0-87.18M-82.17M-76.51M-65.51M-70.69M-62.43M-42M-48.49M-14.32M-52.83M-38.75M-40.87M-34.81M-42.97M-40.22M-36.64M-33.85M-28.51M-24.63M
Net Interest Income010.64M10.35M7.94M8.85M10M9.64M8.86M9.27M4.94M4.64M4.58M4.4M3.77M1.88M553K249K94K55K70K
Interest Income010.71M10.35M8.05M8.92M10.06M9.7M8.92M9.34M5M4.68M4.63M4.45M3.82M1.92M594K290K144K125K98K
Interest Expense-61K69K0108K72K59K60K61K69K52K41K48K55K58K36K41K41K50K70K28K
Other Income/Expense14.92M10.64M10.35M7.94M8.85M10M9.64M8.86M9.27M4.94M4.64M4.58M4.4M3.77M1.88M553K249K94K55K70K
Pretax Income-69.23M-87.25M-82.17M-76.61M-65.58M-70.75M-62.49M-42.06M-48.56M-14.37M-52.87M-38.8M-40.93M-34.87M-43M-40.26M-36.68M-33.9M-28.58M-24.66M
Pretax Margin %-201.47%-3050.8%-2973.05%-667.6%-296.75%-956.88%-1670.33%-163.98%-472.02%-30.01%-1118.17%-234.96%-432.37%-216.03%-450.24%-349.64%-381.25%-221.93%-140.55%-133.16%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-69.23M-87.03M-82.17M-76.61M-65.58M-70.75M-62.49M-42.06M-48.56M-14.37M-52.87M-38.8M-40.93M-34.87M-43M-40.26M-36.68M-33.9M-28.58M-24.66M
Net Margin %-201.47%-3043.01%-2973.05%-667.6%-296.75%-956.88%-1670.33%-163.98%-472.02%-30.01%-1118.17%-234.96%-432.37%-216.03%-450.24%-349.64%-381.25%-221.94%-140.55%-133.16%
Net Income Growth %-5.57%-23.01%-31.51%-82.15%-35.06%-392.43%-18.2%-8.41%-18.64%58.79%-22.94%3.62%-11.57%-2.84%-50.45%-63.25%-180.57%-167.25%-257.9%-76.28%
Net Income (Continuing)-69.23M-87.25M-82.17M-76.61M-65.58M-70.75M-62.49M-42.06M-48.56M-14.37M-52.87M-38.8M-40.93M-34.87M-43M-40.26M-36.68M-33.9M-28.58M-24.66M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.71-0.98-0.94-0.95-0.82-0.88-0.82-0.58-0.69-0.25-0.90-0.67-0.63-0.59-0.79-0.77-0.71-0.66-0.56-0.55
EPS Growth %13.41%-11.36%-14.63%-63.79%-18.84%-252%8.89%13.43%-9.52%57.63%-13.92%12.99%11.27%10.61%-41.07%-40%-144.83%-127.59%-211.11%-71.88%
EPS (Basic)-0.71-0.98-0.94-0.95-0.82-0.88-0.82-0.58-0.69-0.25-0.90-0.67-0.63-0.59-0.79-0.77-0.71-0.66-0.56-0.55
Diluted Shares Outstanding97.53M84.39M87.3M80.45M80.15M79.99M76.13M73.06M70.77M58.52M58.42M58.33M58.19M57.89M54.54M51.77M51.65M51.39M50.71M45.09M
Basic Shares Outstanding97.53M84.39M87.3M80.45M80.15M79.99M76.13M73.06M70.77M58.52M58.42M58.33M58.19M57.89M54.54M51.77M51.65M51.39M50.71M45.09M
Dividend Payout Ratio--------------------